Multiple Dose Healthy Volunteer Study of PF-03715455. (MD-MULTI DOSE)

Pfizer

Status and phase: Completed; Phase 1

Conditions: Healthy Volunteers

Treatments: Drug: Placebo; Drug: PF-03715455

Study type: Interventional

Funder types: Industry

Identifiers

NCT01186757

A9111002

Details and patient eligibility

About

Evaluation of the multiple dose pharmacokinetics of PF-3715455 in healthy volunteers

Full description

Healthy volunteer PK study

Enrollment: 36 patients

Sex: All

Ages: 21 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteers

Exclusion criteria

• Standard healthy volunteer criteria

Trial design

36 participants in 4 patient groups, including a placebo group

PF-03715455 1.6mg BID

Active Comparator group

Treatment:

Drug: PF-03715455

Drug: PF-03715455

Drug: PF-03715455

PF-03715455 4 mg BID

Active Comparator group

Treatment:

Drug: PF-03715455

Drug: PF-03715455

Drug: PF-03715455

PF-03715455 10 mg BID

Active Comparator group

Treatment:

Drug: PF-03715455

Drug: PF-03715455

Drug: PF-03715455

Placebo

Placebo Comparator group

Treatment:

Drug: Placebo